POSTN and Hepatic fibrosis: These findings provide insights into a unique perspective on the potential mechanism of liver fibrosis, and targeting of Bmp-1 and Periostin to normalize pro-fibrotic cellular crosstalk presents a promising therapeutic strategy for patients with liver fibrosis.